Common Contracts
1 similar Managed Access Agreement contracts
Contract Variation Agreement No. 1 to the Managed Access Agreement for Asfotase alfa (Strensiq®) for treating paediatric-onset hypophosphatasiaManaged Access Agreement • September 8th, 2021
Contract/Variation Reference: On 02 August 2017, NHS England and NHS Improvement (NHSE&I), Alexion Pharma UK Ltd., NICE together with two other parties (collectively the “Parties” and each a “Party”) entered into the “Managed Access Agreement for Asfotase alfa (Strensiq®) for treating paediatric-onset hypophatasia (the “MAA”).
